Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M Val T Lobo"'
Autor:
Águeda González-Rodríguez, Ángela M. Valverde, Borja Hernández-Breijo, Ma Dolores Fernández-Moreno, Jorge Monserrat, Javier P. Gisbert, Irene D Román, M Val T Lobo, Luis G. Guijarro
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
et al.
Hepatoblastoma is a primary liver cancer that affects children, due to the sensitivity of this tumor to insulin-like growth factor 1 (IGF-1). In this paper we show that azathioprine (AZA) is capable of inhibiting IGF1-mediated signaling c
Hepatoblastoma is a primary liver cancer that affects children, due to the sensitivity of this tumor to insulin-like growth factor 1 (IGF-1). In this paper we show that azathioprine (AZA) is capable of inhibiting IGF1-mediated signaling c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e5e212164ff8512b38c44246b09af34
https://doi.org/10.1016/j.taap.2013.07.024
https://doi.org/10.1016/j.taap.2013.07.024
Autor:
Silvia Sacristán, M Val T Lobo, Mercedes García-Villanueva, M. Isabel Pérez-Morgado, M. Elena Martín, Sonia Tejada, Matilde Salinas
Publikováno v:
Journal of Histochemistry & Cytochemistry. 57:503-512
Increased protein synthesis is regulated, in part, by two eukaryotic translation initiation factors (eIFs): eIF4E and eIF2α. One or both of these factors are often overexpressed in several types of cancer cells; however, no data are available at pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c836b70733ef2ea8a809a00a4a8c06
https://doi.org/10.1369/jhc.2009.952929
https://doi.org/10.1369/jhc.2009.952929
Autor:
D. Cano-Martínez, Irene Moreno-Villena, Irene D Román, Alberto Paradela, Patricia Sanmartín-Salinas, Jorge Monserrat, Óscar Pastor, M Val T Lobo, Borja Hernández-Breijo, Ma Dolores Fernández-Moreno, Luis G. Guijarro, Javier P. Gisbert
Publikováno v:
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 19(8)
Infliximab (IFX) is widely used in ulcerative colitis and in Crohn’s disease treatment. Both diseases are characterised by increased oxidative stress, which may affect albumin oxidation. In order to test this hypothesis, the effect of IFX on coliti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62ce0515c719643e78c00c511e4a2758
https://pubmed.ncbi.nlm.nih.gov/25382460
https://pubmed.ncbi.nlm.nih.gov/25382460